Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assessment up to 36 Weeks of Treatment

Hoffman, J. E., Bumma, N., Richter, J., Dhodapkar, M. V., Lee, H. C., Suvannasankha, A., Houde, C. A., Maly, J. J., Shah, M. R., Baz, R., Namburi, S., Wu, K. L., Pianko, M., Ye, J. C., Lentzsch, S., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Jagannath, S. (2023). Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assessment up to 36 Weeks of Treatment. Blood, 142(Supplement 1), 3359–3359. https://doi.org/10.1182/blood-2023-179170
Authors:
James E. Hoffman
Naresh Bumma
Joshua Richter
Madhav V. Dhodapkar
Hans C. Lee
Attaya Suvannasankha
Christiane Houde
Joseph Maly
Mansi Shah
Rachid Baz
Swathi Namburi
Ka Lung Wu
Matthew J. Pianko
Jing Christine Ye
Suzanne Lentzsch
Rebecca Silbermann
Chang‐Ki Min
Marie‐Christiane Vekemans
Markus Munder
Ja Min Byun
Joaquín Martínez‐López
Michelle DeVeaux
Cristina Ivanescu
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Timothy J. Inocencio
Lei Chi
James Harnett
Qiufei Ma
Sundar Jagannath
Affiliated Authors:
Suzanne Lentzsch
Columbia Affiliation:
Subjects:
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Synthesis and Biological Activities of Quinoxaline Derivatives (OpenAlex Topic)
Role of Fibroblast Activation in Cancer Progression (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-179170
DOI:
10.1182/blood-2023-179170
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: